Cormorant Asset Management, LP - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 90 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2018$2,460,000
-80.8%
400,000
-66.7%
0.16%
-83.1%
Q2 2018$12,828,000
-36.4%
1,200,000
-36.2%
0.95%
-36.9%
Q1 2018$20,182,000
+48.5%
1,880,880
-3.1%
1.50%
+5.8%
Q4 2017$13,586,000
-19.9%
1,940,8800.0%1.42%
-52.5%
Q3 2017$16,963,000
-4.1%
1,940,8800.0%3.00%
+2.2%
Q2 2017$17,681,000
+14.7%
1,940,8800.0%2.93%
+31.0%
Q1 2017$15,411,000
-26.1%
1,940,880
-16.8%
2.24%
-20.4%
Q4 2016$20,860,000
-39.5%
2,333,333
+17.4%
2.81%
-26.1%
Q3 2016$34,496,000
+147.5%
1,988,2080.0%3.80%
+92.5%
Q2 2016$13,937,0001,988,2081.98%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2018
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders